Skip to main content
. Author manuscript; available in PMC: 2010 Jul 10.
Published in final edited form as: Toxicol Lett. 2009 Mar 20;188(1):38–44. doi: 10.1016/j.toxlet.2009.03.005

Fig. 5. Immunohistochemical localization of Mcl-1.

Fig. 5

The localization pattern of activated Mcl-1 was altered between the groups with hepatocellular damage (cytoplasmic) and those without damage (nuclear). A minimum of two animals per treatment group were evaluated for IHC and pictures are representative of treatment group pathology. 20× magnification.